RUBIFEN FOR SALE

Description

rubifen for sale Rubifen immediate release 5, 10 and 20 mg tablets: round white tablet with slightly bevelled edges,
marked RU-5, RU-10 or RU-20 containing 5 mg, 10 mg and 20 mg methylphenidate respectively with
a score mark on the 10 mg tablets.
Rubifen sustained release 20 mg tablets: oblong white or white-cream smooth tablet containing 20 mg
methylphenidate in a modified release formulation.rubifen for sale

ADHD was previously known as attention-deficit disorder or minimal brain dysfunction. Other terms
used to describe this behavioural syndrome include: hyperkinetic disorder, minimal brain damage,
minimal cerebral dysfunction, minor cerebral dysfunction and psycho-organic syndrome of children.
Rubifen is indicated as part of a comprehensive treatment program which typically includes
psychological, educational and social measures and is aimed at stabilising children with a behavioural
syndrome characterised by moderate to severe distractibility, short attention span, hyperactivity,
emotional lability and impulsivity. The diagnosis should be made according to DSM-IV criteria or the
guidelines in ICD-10. Non-localising (soft) neurological signs, learning disability and abnormal EEG
may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be
warranted.Characteristics commonly reported include: history of short attention span, distractibility, emotional
lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and abnormal EEG.
Learning may or may not be impaired. The diagnosis must be based upon a complete history and
evaluation of the child and not solely on the presence of one or more of these characteristics. Drug
treatment is not indicated in all children with this syndrome. Stimulants are not indicated in children
with symptoms secondary to environmental factors (child abuse in particular) and/or primary
psychiatric disorder, including psychosis. Appropriate educational placement is essential, and
psychosocial intervention is generally necessary. Where remedial measures alone prove insufficient,
the decision to prescribe a stimulant must be based on rigorous assessment of the severity of the child’s
symptoms.
Narcolepsy
Symptoms include daytime sleepiness, inappropriate sleep episodes, and sudden loss of voluntary
muscle tone.